arrow_back Back to App

Increased Brain Aneurysm Research: Ellie's Law

This act boosts funding for research into unruptured brain aneurysms to improve understanding and treatment. The goal is to enhance diagnosis and care, potentially saving lives and reducing suffering for many in the future.
Key points
Increased funding for brain aneurysm research by $20 million annually for five years (2026-2030).
Research will include a broader patient population, considering age, sex, and race, to better understand the condition across diverse individuals.
The aim is to improve early detection and treatment of aneurysms, potentially reducing deaths and permanent neurological damage.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_2678
Sponsor: Rep. Fitzpatrick, Brian K. [R-PA-1]
Process start date: 2025-04-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Ellie’s Law

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_2678.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-04-07.

What are the main provisions?

Key points include:

  • Increased funding for brain aneurysm research by $20 million annually for five years (2026-2030).
  • Research will include a broader patient population, considering age, sex, and race, to better understand the condition across diverse individuals.
  • The aim is to improve early detection and treatment of aneurysms, potentially reducing deaths and permanent neurological damage.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Fitzpatrick, Brian K. [R-PA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health